The effects of proton pump inhibitors on neuropsychological functioning

References

• Abad, F. J., Sorrel, M. A., Román, F. J., & Colom, R. (2016). The relationships between WAIS-IV factor index scores and educational level: A bifactor model approach. Psychological Assessment, 28(8), 987–1000. https://doi.org/10.1037/pas0000228
   PubMed Web of Science ®Google Scholar
• Aging Brain Care. Anticholinergic Cognitive Burden scale: 2012 update; Retrieved January 1, 2020, from, http://www.agingbraincare.org/uploads/products/ACB_scale_-_legal_size.pdf
   Google Scholar
• Akter, S., Hassan, M. R., Shahriar, M., Akter, N., Abbas, M. G., & Bhuiyan, M. A. (2015). Cognitive impact after short-term exposure to different PPIs: Assessment using CANTAB software. Alzheimer’s Research & Therapy, 7(1), 79. https://doi.org/10.1186/s13195-015-0164-8
   PubMedGoogle Scholar
• Allen, S. J., MacGowan, S. H., Tyler, S., Wilcock, G. K., Robertson, A. G. S., Holden, P. H., Smith, S. K. F., & Dawbarn, D. (1997). Reduced cholinergic function in normal and Alzheimer’s disease 456 brain is associated with apolipoprotein E4 genotype. Neuroscience Letters, 239(1), 33–36. https://doi.org/10.1016/S0304-3940(97)00872-0
   PubMed Web of Science ®Google Scholar
• Badiola, N., Alcalde, V., Pujol, A., Münter, L.-M., Multhaup, G., Lleó, A., Coma, M., Soler-López, M., & Aloy, P. (2013). The proton-pump inhibitor lansoprazole enhances amyloid beta production. PloS One, 8(3), e58837. https://doi.org/10.1371/journal.pone.0058837
   PubMed Web of Science ®Google Scholar
• Batchelor, R., Gilmartin, J. F. M., Kemp, W., Hopper, I., & Liew, D. (2017). Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review. European Journal of Gastroenterology & Hepatology, 32(8), 1426–1435. https://doi.org/10.1111/jgh.13750
   Google Scholar
• Benjamini, Y., & Yekutieli, D. (2005). False discovery rate–adjusted multiple confidence intervals for selected parameters. Journal of the American Statistical Association, 100(469), 71–81. https://doi.org/10.1198/016214504000001907
   Web of Science ®Google Scholar
• Bennett, D. A. (2001). How can I deal with missing data in my study? Australian and New Zealand Journal of Public Health, 25(5), 464–469. https://doi.org/10.1111/j.1467-842X.2001.tb00294.x
   PubMed Web of Science ®Google Scholar
• Bentley, P., Driver, J., & Dolan, R. J. (2011). Cholinergic modulation of cognition: Insights from human pharmacological functional neuroimaging. Progress in Neurobiology, 94(4), 360–388. https://doi.org/10.1016/j.pneurobio.2011.06.002
   PubMed Web of Science ®Google Scholar
• Booker, A., Jacob, L. E., Rapp, M., Bohlken, J., & Kostev, K. (2016). Risk factors for dementia diagnosis in German primary care practices. International Psychogeriatrics, 28(7), 1059–1065. https://doi.org/10.1017/S1041610215002082
   PubMed Web of Science ®Google Scholar
• Clark, L. R., Koscik, R. L., Nicholas, C. R., Okonkwo, O. C., Engelman, C. D., Bratzke, L. C., Hogan, K. J., Mueller, K. D., Bendlin, B. B., Carlsson, C. M., Asthana, S., Sager, M. A., Hermann, B. P., & Johnson, S. C. (2016). Mild cognitive impairment in late middle age in the Wisconsin Registry for Alzheimer’s Prevention Study: Prevalence and characteristics using robust and standard neuropsychological normative data. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists, 31(7), 675–688. https://doi.org/10.1093/arclin/acw024
   PubMed Web of Science ®Google Scholar
• Eckart, C., & Bunzeck, N. (2013). Dopamine modulates processing speed in the human mesolimbic system. NeuroImage, 66, 293–300. https://doi.org/10.1016/j.neuroimage.2012.11.001
   PubMed Web of Science ®Google Scholar
• Eldufani, J., & Blaise, G. (2019). The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applications. Alzheimer’s & Dementia. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 5(1), 175–183. https://doi.org/10.1016/j.trci.2019.03.004
   PubMedGoogle Scholar
• El-Serag, H. B., Sweet, S., Winchester, C. C., & Dent, J. (2014). Update on the epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut, 63(6), 871–880. https://doi.org/10.1136/gutjnl-2012-304269
   PubMed Web of Science ®Google Scholar
• Folstein, M. F., Robins, L. N., & Helzer, J. E. (1983). The Mini-Mental State 503 Examination. Archives of General Psychiatry, 40(7), 812. https://doi.org/10.1001/archpsyc.1983.01790060110016
   PubMed Web of Science ®Google Scholar
• Gawel, K., Labuz, K., Gibula-Bruzda, E., Jenda, M., Marszalek-Grabska, M., Filarowska, J., Silberring, J., & Kotlinska, J. H. (2016). Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats. Naunyn-Schmiedeberg’s Archives of Pharmacology, 389(10), 1059–1071. https://doi.org/10.1007/s00210-016-1269-8
   PubMed Web of Science ®Google Scholar
• Goldstein, F. C., Steenland, K., Zhao, L., Wharton, W., Levey, A. I., & Hajjar, I. (2017). Proton pump inhibitors and risk of mild cognitive impairment and Dementia. Journal of the American Geriatrics Society, 65(9), 1969–1974. https://doi.org/10.1111/jgs.14956
   PubMed Web of Science ®Google Scholar
• Gomm, W., von Holt, K., Thomé, F., Broich, K., Maier, W., Fink, A., Doblhammer, G., & Haenisch, B. (2016). Association of PPIs with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurology, 73(4), 410–416. https://doi.org/10.1001/jamaneurol.2015.4791
   PubMed Web of Science ®Google Scholar
• Gray, S. L., Walker, R. L., Dublin, S., Yu, O., Aiello Bowles, E. J., Anderson, M. L., Crane, P. K., & Larson, E. B. (2018). Proton pump inhibitor use and dementia risk: Prospective population-based study. Journal of the American Geriatrics Society, 66(2), 247–253. https://doi.org/10.1111/jgs.15073
   PubMed Web of Science ®Google Scholar
• Haenisch, B., von Holt, K., Wiese, B., Prokein, J., Lange, C., Ernst, A., Brettschneider, C., König, H.-H., Werle, J., Weyerer, S., Luppa, M., Riedel-Heller, S. G., Fuchs, A., Pentzek, M., Weeg, D., Bickel, H., Broich, K., Jessen, F., Maier, W., & Scherer, M. (2015). Risk of dementia in elderly patients with the use of proton pump inhibitors. European Archives of Psychiatry and Clinical Neuroscience, 265(5), 419–428. https://doi.org/10.1007/s00406-014-0554-0
   PubMed Web of Science ®Google Scholar
• Huang, Y. W. A., Zhou, B., Wernig, M., & Südhof, T. C. (2017). ApoE2, ApoE3, and APoε4 differentially stimulate APP transcription and Aβ secretion. Cell, 168(3), 427–441. https://doi.org/10.1016/j.cell.2016.12.044
   PubMed Web of Science ®Google Scholar
• IBM. (2019). SPSS Statistics Version 26. IBM Corp.
   Google Scholar
• Johnson, S. C., Koscik, R. L., Jonaitis, E. M., Clark, L. R., Mueller, K. D., Berman, S. E., Bendlin, B. B., Engelman, C. D., Okonkwo, O. C., Hogan, K. J., Asthana, S., Carlsson, C. M., Hermann, B. P., & Sager, M. A. (2018). The Wisconsin Registry for Alzheimer’s Prevention: A review of findings and current directions. Alzheimer’s & Dementia, 10, 130–142. https://doi.org/10.1016/j.dadm.2017.11.007
   Google Scholar
• Kumar, R., Kumar, A., Nordberg, A., Långström, B., & Darreh‐Shori, T. (2020). Proton pump inhibitors act with unprecedented potencies as inhibitors of the acetylcholine biosynthesizing enzyme—A plausible missing link for their association with incidence of dementia. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 16(7), 1031–1042. https://doi.org/10.1002/alz.12113
   PubMed Web of Science ®Google Scholar
• Lezak, M., Howieson, D., Bigler, E., & Tranel, D. (2012). Neuropsychological Assessment – Fifth Edition. Oxford University Press.
   Google Scholar
• Lochhead, P., Hagan, K., Joshi, A. D., Khalili, H., Nguyen, L. H., Grodstein, F., & Chan, A. T. (2017). Association between PPI use and cognitive function in women. Gastroenterology, 153(4), 971–979. https://doi.org/10.1053/j.gastro.2017.06.061
   PubMed Web of Science ®Google Scholar
• Mulsant, B. H., Pollock, B. G., Kirshner, M., Shen, C., Dodge, H., & Ganguli, M. (2003). Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance. Archives of General Psychiatry, 60(2), 198–203. https://doi.org/10.1001/archpsyc.60.2.198
   PubMed Web of Science ®Google Scholar
• Nebes, R. D., Pollock, B. G., Perera, S., Halligan, E. M., & Saxton, J. A. (2012). The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk. The American Journal of Geriatric Pharmacotherapy, 10(3), 185–192. 570 https://doi.org/10.1016/j.amjopharm.2012.03.003
   PubMedGoogle Scholar
• Nikiforuk, A., Kos, T., Potasiewicz, A., & Popik, P. (2015). Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 25(8), 1300–1313. https://doi.org/10.1016/j.euroneuro.2015.04.018
   PubMed Web of Science ®Google Scholar
• Nishita, Y., Tange, C., Tomida, M., Ando, F., & Shimokata, H. (2013). Does high educational level protect against intellectual decline in older adults? A 10-year longitudinal study. Japanese Psychological Research, 55(4), 378–389. https://doi.org/10.1111/jpr.12028
   Web of Science ®Google Scholar
• Ortiz-Guerrero, G., Amador-Muñoz, D., Calderón-Ospina, C. A., López-Fuentes, D., & Nava Mesa, M. O. (2018). Proton pump inhibitors and dementia: Physiopathological mechanisms and clinical consequences. Neural Plasticity, 2018, 5257285. https://doi.org/10.1155/2018/5257285
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general 584 population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306
   Web of Science ®Google Scholar
• Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271–276. https://doi.org/10.2466/pms.1958.8.3.271
   Google Scholar
• Schmidt, M. (1996). Rey auditory verbal learning test: A handbook (p. 1996). Western Psychological Services.
   Google Scholar
• Sodhi, R. K., & Singh, N. (2013). Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet. PLoS One, 8(7), e70487. https://doi.org/10.1371/journal.pone.0070487
   PubMedGoogle Scholar
• Tai, S. Y., Chien, C. Y., Wu, D. C., Lin, K. D., Ho, B. L., Chang, Y. H., & Chang, Y. P. (2017). Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan. PLoS One, 12(2), e0171006. https://doi.org/10.1371/journal.pone.0171006
   PubMed Web of Science ®Google Scholar
• Taipale, H., Tolppanen, A. M., Tiihonen, M., Tanskanen, A., Tiihonen, J., & Hartikainen, S. (2017). No association between proton pump inhibitor use and risk of Alzheimer’s disease. The American Journal of Gastroenterology, 112(12), 1802.
   PubMed Web of Science ®Google Scholar
• Wechsler, D. (1997). Wechsler adult intelligence scale – Third Edition. The Psychological Corporation.
   Google Scholar
• Wechsler, D. (1999). Wechsler abbreviated scale of intelligence. The Psychological Corporation: Harcourt Brace & Company.
   Google Scholar
• West, B. T., Welch, K. B., & Galecki, A. T. (2007). Linear mixed models: A practical guide using statistical software. Chapman and Hall/CRC.
   Google Scholar
• Wijarnpreecha, K., Thongprayoon, C., Panjawatanan, P., & Ungprasert, P. (2016). Proton pump inhibitors and risk of dementia. Annals of Translational Medicine, 4(12), 240–240. https://doi.org/10.21037/atm.2016.06.14
   PubMed Web of Science ®Google Scholar
• Wilson, R. S., Hebert, L. E., Scherr, P. A., Barnes, L. L., Mendes de Leon, C. F., & Evans, D. A. (2009). Educational attainment and cognitive decline in old age. Neurology, 72(5), 460–465. https://doi.org/10.1212/01.wnl.0000341782.71418.6c
   PubMed Web of Science ®Google Scholar